$2.15
0.210.39%
Pre-Market: 7:37 PM EDT
15 minutes delayed
CareMax
CMAXNASDAQ
CareMax (NASDAQ:CMAX) Stock, Analyst Ratings, Price Targets, Forecasts
CareMax Inc has a consensus price target of $8.48 based on the ratings of 6 analysts. The high is $15 issued by Jefferies on October 20, 2021. The low is $2 issued by Piper Sandler on November 10, 2023. The 3 most-recent analyst ratings were released by UBS, UBS, and Piper Sandler on April 1, 2024, November 17, 2023, and November 10, 2023, respectively. With an average price target of $3.13 between UBS, UBS, and Piper Sandler, there's an implied 45.55% upside for CareMax Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
Piper Sandler
UBS
Truist Securities
Jefferies
1calculated from analyst ratings
Analyst Ratings for CareMax
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | Buy Now | 197.3% | UBS | A.J. Rice | $7 → $6.4 | Maintains | Neutral | Get Alert |
| 11/17/2023 | Buy Now | -53.55% | UBS | A.J. Rice | $150 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 11/10/2023 | Buy Now | -7.09% | Piper Sandler | Jessica Tassan | → $60 | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 178.72% | UBS | Andrew Mok | $300 → $180 | Maintains | Buy | Get Alert |
| 09/07/2022 | Buy Now | 248.4% | Truist Securities | Jailendra Singh | → $225 | Initiates | → Hold | Get Alert |
| 10/20/2021 | Buy Now | 596.8% | Jefferies | Brian Tanquilut | → $450 | Initiates | → Buy | Get Alert |
| 09/13/2021 | Buy Now | — | Piper Sandler | Jessica Tassan | — | Upgrade | Neutral → Overweight | Get Alert |
| 09/10/2021 | Buy Now | 550.35% | Cowen & Co. | Gary Taylor | → $420 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for CareMax (CMAX) stock?
The latest price target for CareMax (NASDAQ:CMAX) was reported by UBS on April 1, 2024. The analyst firm set a price target for $6.40 expecting CMAX to rise to within 12 months (a possible 197.30% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CareMax (CMAX)?
The latest analyst rating for CareMax (NASDAQ:CMAX) was provided by UBS, and CareMax maintained their neutral rating.
When was the last upgrade for CareMax (CMAX)?
The last upgrade for CareMax Inc happened on September 13, 2021 when Piper Sandler raised their price target to N/A. Piper Sandler previously had a neutral for CareMax Inc.
When was the last downgrade for CareMax (CMAX)?
The last downgrade for CareMax Inc happened on November 17, 2023 when UBS changed their price target from $5 to $1 for CareMax Inc.
When is the next analyst rating going to be posted or updated for CareMax (CMAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CareMax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CareMax was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating CareMax (CMAX) correct?
While ratings are subjective and will change, the latest CareMax (CMAX) rating was a maintained with a price target of $7.00 to $6.40. The current price CareMax (CMAX) is trading at is $2.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.